Rocket Pharmaceuticals Inc $ 55.58 3.72 (7.17%)
Volume:
446,587
Avg Vol (1m):
479,955
Market Cap $:
3.37 Bil
Enterprise Value $:
3.21 Bil
PE Ratio:
0.00
PB Ratio:
12.67
Financial Strength | 4/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Cash-To-Debt | 3.32 | ||
Debt-to-Equity | 0.28 | ||
Debt-to-EBITDA | -0.76 | ||
Piotroski F-Score | 2 | ||
WACC vs ROIC |
Profitability Rank | 1/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
ROE % | -36.98 | ||
ROA % | -28.45 | ||
ROC (Joel Greenblatt) % | -185.46 | ||
3-Year EBITDA Growth Rate | 38.4 | ||
3-Year EPS without NRI Growth Rate | 37.3 |
RCKT
Valuation Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
PB Ratio | 12.67 | ||
EV-to-EBIT | -34.94 | ||
EV-to-EBITDA | -35.22 | ||
Current Ratio | 7.3 | ||
Quick Ratio | 7.3 |
Dividend & Buy Back |
Current | Vs Industry | Vs History | |
---|---|---|---|
3-Year Average Share Buyback Ratio | -101 |
Valuation & Return |
Current | Vs Industry | Vs History | |
---|---|---|---|
Price-to-Tangible-Book | 14.55 | ||
Earnings Yield (Greenblatt) % | -2.87 |